9 and  2CDR3 domains regulate functional avidity of T cells harboring  9 2TCRs

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human    T-cell subset

(2012) C. Harly et al.   BLOOD

γδ T Cell Receptors Recognize the Non-classical Major Histocompatibility Complex (MHC) Molecule T22 via Conserved Anchor Residues in a MHC Peptide-like Fashion

(2012) Andrew Sandstrom et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor

(2012) Carrie R Willcox et al.   NATURE IMMUNOLOGY

Redirecting   T cells against cancer cells by transfer of a broadly tumor-reactive   T-cell receptor

(2011) V. Marcu-Malina et al.   BLOOD

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours

(2011) A J Nicol et al.   BRITISH JOURNAL OF CANCER

Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside

(2011) Barbara Castella et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Searching for “signal 2”: costimulation requirements of γδ T cells

(2011) Julie C. Ribot et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Peptide antigens for gamma/delta T cells

(2011) Willi K. Born et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study

(2011) S. van Dorp et al.   HAEMATOLOGICA

Targeting    T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application

(2010) A. Q. Gomes et al.   CANCER RESEARCH

Repertoire Development and the Control of Cytotoxic/Effector Function in HumanγδT Cells

(2010) Elizabeth M. Urban et al.   Clinical & Developmental Immunology

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

(2010) Melissa A. Geller et al.   CYTOTHERAPY

V 2V 2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs

(2010) H. Wang et al.   JOURNAL OF IMMUNOLOGY

Human Vγ9Vδ2 T cells: From signals to functions

(2010) Steven Nedellec et al.   SEMINARS IN IMMUNOLOGY

Re-targeting T-cells against cancer by gene-transfer of tumor-reactive receptors

(2009) Victoria Marcu-Malina et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Increasing functional avidity of TCR-redirected T cells by removing definedN-glycosylation sites in the TCR constant domain

(2009) Jürgen Kuball et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody

(2008) Wim K. Bleeker et al.   BRITISH JOURNAL OF HAEMATOLOGY

Natural killer cell immunotherapy for cancer: a new hope

(2008) S. Srivastava et al.   CYTOTHERAPY